A Swedish prospective, observational study of health related quality of life over 6 months in patients with overactive bladder starting treatment with Tolterodine SR

Abstract Category

Quality of Life (QoL)

Links
	Abstract 463
	Read By Title Scientific Non Discussion Abstract Session 19
	1. Department of Urology, Sahlgrenska University Hospital Goteborg, Goteborg, Sweden., 2. Pfizer AB, Sollentuna, Sweden
Abstract PDF Edit Abstract Abstract Centre